These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 269689

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prothrombin complex concentrate.
    DeWitt RT, Feinstein DI.
    Arch Intern Med; 1977 Sep; 137(9):1211-3. PubMed ID: 901090
    [Abstract] [Full Text] [Related]

  • 23. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K, Nowotny C, Krinninger B, Zegner M, Deutsch E.
    Thromb Haemost; 1979 Feb 15; 40(3):478-85. PubMed ID: 425062
    [Abstract] [Full Text] [Related]

  • 24. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM, Ménaché D, Roberts HR.
    Thromb Haemost; 1980 Aug 29; 44(1):39-42. PubMed ID: 6775386
    [Abstract] [Full Text] [Related]

  • 25. Apheresis.
    Nilsson IM, Freiburghaus C.
    Adv Exp Med Biol; 1995 Aug 29; 386():175-84. PubMed ID: 8851026
    [Abstract] [Full Text] [Related]

  • 26. Spontaneous inhibitors to coagulation factors.
    Green D.
    Clin Lab Haematol; 2000 Oct 29; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S, Cattaneo M, Gervasoni W, Mannucci PM.
    Thromb Haemost; 1980 Oct 31; 44(2):72-5. PubMed ID: 6779400
    [Abstract] [Full Text] [Related]

  • 31. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A, Zieleniewska B.
    Acta Haematol Pol; 1994 Oct 31; 25(4):349-54. PubMed ID: 7847036
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose.
    Van Leeuwen EF, Mauser-Bunschoten EP, Van Dijken PJ, Kok AJ, Sjamsoedin-Visser EJ, Sixma JJ.
    Br J Haematol; 1986 Oct 31; 64(2):291-7. PubMed ID: 3096366
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM, Penner JA.
    N Engl J Med; 1974 Jul 25; 291(4):164-7. PubMed ID: 4834485
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.